The Complexities and Art of Interpreting Biomarkers and Response to Immune Checkpoint Inhibitors

Oncology (Williston Park). 2023 May 9;37(5):216-217. doi: 10.46883/2023.25920996.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Biomarkers, Tumor
  • Humans
  • Immune Checkpoint Inhibitors* / therapeutic use
  • Immunotherapy
  • Neoplasms* / drug therapy

Substances

  • Immune Checkpoint Inhibitors
  • Biomarkers
  • Biomarkers, Tumor